Logo CICANCER

CIC Events

Deep learning and bioinformatics on human large-scale transcriptomic data: studies of neurodegeneration and cancer 22/04/2021

Deep learning and bioinformatics on human large-scale transcriptomic data: studies of neurodegeneration and cancer

Óscar González-Velasco — Centro de Investigación del Cáncer (CIC-IBMCC)

tRNA biology in health and disease: from expanding proteome diversity to promising biomarkers in medicine 29/04/2021

tRNA biology in health and disease: from expanding proteome diversity to promising biomarkers in medicine

Adrian Gabriel Torres — Institut de Recerca Biomèdica de Barcelona

Critical requirement of SOS1 RAS-GEF function for mitochondrial dynamics, metabolism and redox homeostasis 06/05/2021

Critical requirement of SOS1 RAS-GEF function for mitochondrial dynamics, metabolism and redox homeostasis

Rósula García Navas — Centro de Investigación del Cáncer (CIC-IBMCC)

Mechanisms of KRAS signaling in lung cancer development 13/05/2021

Mechanisms of KRAS signaling in lung cancer development

Dr. Mattias Drösten — Centro Nacional de Investigaciones Oncológicas CNIO

Control of Actin Polymerization in Cells Through Activation and Inhibition of the Arp2/3 Complex 24/06/2021

Control of Actin Polymerization in Cells Through Activation and Inhibition of the Arp2/3 Complex

Roberto Domínguez — Department of Physiology. University of Pennsylvania. Perelman School of Medicine (Philadelphia, USA)



Past Events

Decoding the epitranscriptome at single molecule resolution 15/04/2021

Decoding the epitranscriptome at single molecule resolution

Eva Novoa — Center for Genomic Regulation (CRG) de Barcelona

Role of C3G in megakaryopoiesis, hypoxia-induced angiogenesis and melanoma metastasis. 08/04/2021

Role of C3G in megakaryopoiesis, hypoxia-induced angiogenesis and melanoma metastasis.

Luis Hernández — Centro de Investigación del Cáncer (CIC-IBMCC)

HER-3 targeting with an antibody-drug conjugate 25/03/2021

HER-3 targeting with an antibody-drug conjugate

Lucía Gandullo — Centro de Investigación del Cáncer (CIC-IBMCC, Universidad de Salamanca-CSIC)